Advertisement

Topics

Chugai Deploys RaveX to Modernize Post-Marketing Surveillance

19:30 EDT 29 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Tokyo-based Pharmaceutical Company Expands Use of Medidata’s Unified Technology Platform to Simplify Study Navigation, Improve Data Quality and Speed Data Entry Times Medidata (NASDAQ:MDSO), the leading global provi...

Other Sources for this Article

Medidata
Investors:
Anthony D’Amico, +1-732-767-4331
adamico@mdsol.com
or
Media:
Erik Snider, +1-646-362-2997
esnider@mdsol.com

NEXT ARTICLE

More From BioPortfolio on "Chugai Deploys RaveX to Modernize Post-Marketing Surveillance"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...